Pharmafile Logo
Pharmafocus logo
Advanced Search

AM-Pharma appoints new chief executive

September 13, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dutch biopharmaceutical company AM-Pharma has appointed Erik van den Berg as its new chief executive. He was previously VP business …

Appointment
Genzyme

Genzyme confirms further Fabrazyme delay

September 13, 2011
Manufacturing and Production Fabrazyme, Genzyme, pharma manufacturing news

Genzyme has been forced to delay shipments of its Fabry disease treatment Fabrazyme once again, blaming its “quality release process”. …

News

Slow Provenge growth prompts Dendreon staff cull

September 13, 2011
Business Services, Manufacturing and Production Dendreon, Provenge, job cuts, pharma manufacturing news

After months of building manufacturing capacity, US biotech Dendreon has decided to slash a quarter of its workforce – with …

News

Aurobindo forms Russian joint venture with Diod

September 13, 2011
Manufacturing and Production, Sales and Marketing Aurobindo, Diod, pharma manufacturing news

Indian drugmaker Aurobindo has formed a joint venture with Russia’s OJSC Diod in order to tap into the local market …

News

Offshoring pharma manufacturing increases risk, says study

September 12, 2011
Manufacturing and Production Puerto Rico, contract manufacturing, pharma manufacturing news

Drugs produced in offshore manufacturing plants – even those run by US manufacturers – pose a greater quality risk than …

News

Pharma manufacturing news in brief

September 12, 2011
Manufacturing and Production pharma manufacturing news

DMV-Fonterra agrees to buy India’s Brahmar Cellulose, plus there are facility updates from Reliable and Toyoba, some bad press for …

News
research_partnership_richard_head

Richard Head joins the Research Partnership

September 12, 2011
Sales and Marketing appointment, sales and marketing

Market research company the Research Partnership has appointed Richard Head as a director. He will be based at the company’s …

Appointment

FDA recommends Xarelto for new approval

September 12, 2011
Sales and Marketing Xarelto, atrial fibrillation, stroke

FDA advisors have recommended Bayer and Johnson & Johnson’s Xarelto be approved in the US for the prevention of stroke …

News

GSK scales back breast cancer trial

September 12, 2011
Research and Development, Sales and Marketing GSK, Tyverb

GSK has halted one of the four phase III studies that make up the ALTTO programme for its cancer drug …

News

Takeda moves potential first-in-class diabetes drug into phase III

September 12, 2011
Research and Development, Sales and Marketing TAK-875, Takeda, diabetes

Takeda has moved its potential first-in-class diabetes candidate TAK-875 into phase III clinical trials. The company hopes TAK-875 will offer …

News
Blog footer

Digital Pharma: Twitter slip-up shouldn’t silence pharma

September 9, 2011
Medical Communications, Sales and Marketing Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter

Bayer UK was recently ruled to have breached the ABPI Code of Practice by promoting prescription-only medicines to the general …

News

Pan appoints trio of new starters

September 9, 2011
Medical Communications appointment, medical communications

Pan Advertising has appointed a trio of new starters across its creative and client services teams. Maneesh Sharma joins the …

Appointment
1hq_burton_paul

Branding agency 1HQ appoints Burton Paul

September 9, 2011
Medical Communications appointment, medical communications

Burton Paul has joined Windsor, UK-based branding agency 1HQ as client director to head up their health division. He has …

Appointment

EMA grants first paediatric use marketing authorisation

September 9, 2011
Sales and Marketing Buccolam, PUMA, Viropharma, paediatric trials, seizures

The first children’s medicine to hold a new paediatric use marketing authorisation (PUMA), making it available for children only, has …

News
Zytiga

European approval for prostate cancer drug Zytiga

September 8, 2011
Sales and Marketing Janssen, Jevtana, Johnson & Johnson, Zytiga, prostate cancer

Johnson & Johnson’s Zytiga has been approved in the EU for late-stage prostate cancer. Zytiga (abiraterone acetate) is now licenced …

News
Novartis

Everolimus approved to treat rare tumour disease

September 8, 2011
Sales and Marketing Novartis, SEGA, Votubia, everolimus

Novartis has gained EU approval for everolimus to be used to treat a rare non-cancerous tumour. Everolimus is already marketed …

News

New ABPI chief executive to focus on industry reputation

September 8, 2011
Research and Development, Sales and Marketing ABPI, industry relations

The new chief executive of the ABPI used his first public speech to focus on the reputation of the pharma …

News

Sanofi banks on personalised medicine for growth

September 8, 2011
Sales and Marketing Genzyme, Sanofi

Sanofi has nailed its colours to the mast of personalised medicine, banking on the purchase of US biotech company Genzyme, …

News

Algeta appoints first head of comms and investor relations

September 8, 2011
Medical Communications, Research and Development appointment, medical communications, research and development

Norwegian biotech Algeta has appointed Dr Mike Booth to the newly-created role of senior VP of communications and corporate affairs. …

Appointment

Dendreon drops GSK as Provenge manufacturing partner

September 8, 2011
Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news

Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026